Sigma-Aldrich
Home
Investor Relations Investor Relations
Investor Relations

Sigma-Aldrich is a leading Life Science and High technology company. Our biochemical and organic chemical kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and chemical manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Sigma-Aldrich operates in 33 countries and has 6,500 employees providing excellent service worldwide.



News Releases

Date Title (click to view the full text)
3/21/02 Sigma-Aldrich Signs Letter Of Intent To Sell Eia Product Line
2/12/02 Sigma-Aldrich (Nasdaq: Sial) Achieves Long-Term Sales Growth Goal In Q4. Reported Diluted Eps Up 9.8% To $.45 In Q4 And 12.7% To $1.87 For 2001.
1/7/02 New Sigma Catalog is “The Source” for Life Science Research

Sigma-Aldrich

Click here to view the
Sigma-Aldrich 2001 Annual Report



Stock Quote

Minimum 20 minutes delayed

Stock Symbol SIAL
Current Price 45.4
Change -0.21 (down 0.46%)
High 45.53
Low 45.25
Volume 7.300
Last Trade 3/26/02 9:36AM
Stock Exchange NASDAQ
NASDAQ Composite 1817.99 (up 0.3%)
Click for Pop-up Quote
NOTE: The stock price performance shown on the quote above is not necessarily indicative of future price performance.



Transfer Agent
ComputerShare
2 North LaSalle Street
Chicago, IL 60606
Phone (312) 588-4991


© 2002 Sigma-Aldrich Co. Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc.
Best viewed with Internet Explorer version 4.0 and higher